$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.

2014 Q2 Form 10-Q Financial Statement

#000119312514299064 Filed on August 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2 2011
Revenue $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.970M $2.360M $11.96M
YoY Change 25.85% -4.07% 3.1%
% of Gross Profit
Research & Development $1.026M $778.3K $8.808M
YoY Change 31.76% -53.11% 4.61%
% of Gross Profit
Depreciation & Amortization $170.0K $170.0K $7.356K
YoY Change 0.0% 0.0% -98.92%
% of Gross Profit
Operating Expenses $4.160M $778.3K $8.808M
YoY Change 434.46% -81.86% -57.43%
Operating Profit -$4.160M -$3.287M -$21.44M
YoY Change 26.56% -23.29% 3.63%
Interest Expense $3.520M $910.0K $2.010M
YoY Change 286.81% 102.22% -6.07%
% of Operating Profit
Other Income/Expense, Net $3.517M $909.0K
YoY Change 286.91% 100.66%
Pretax Income -$640.0K -$2.380M -$19.43M
YoY Change -73.11% -37.86% 4.74%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$643.0K -$2.378M -$19.43M
YoY Change -72.96% -37.96% 4.76%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.646K -$18.72K -$183.8K
COMMON SHARES
Basic Shares Outstanding 176.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q2 2011
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.13M $4.640M $7.710M
YoY Change 290.73% 14.0% -4.7%
Cash & Equivalents $18.13M $4.636M $7.710M
Short-Term Investments
Other Short-Term Assets $90.00K
YoY Change 28.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $18.13M $4.730M $7.710M
YoY Change 283.21% 14.25% -4.7%
LONG-TERM ASSETS
Property, Plant & Equipment $26.68K $30.00K $20.00K
YoY Change -11.06% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.00K $30.00K $30.00K
YoY Change -10.0% 0.0% 0.0%
Total Long-Term Assets $3.973M $4.640M $5.640M
YoY Change -14.38% -12.95% -10.62%
TOTAL ASSETS
Total Short-Term Assets $18.13M $4.730M $7.710M
Total Long-Term Assets $3.973M $4.640M $5.640M
Total Assets $22.10M $9.370M $13.35M
YoY Change 135.85% -1.06% -7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $480.0K $60.00K $100.0K
YoY Change 700.0% -68.42% -76.19%
Accrued Expenses $340.0K $350.0K $160.0K
YoY Change -2.86% -77.12% -82.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $816.5K $410.0K $260.0K
YoY Change 99.14% -76.16% -80.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $2.610M $3.070M
YoY Change -50.19% -9.38% 30.64%
Total Long-Term Liabilities $1.300M $2.610M $3.070M
YoY Change -50.19% -9.38% 30.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $816.5K $410.0K $260.0K
Total Long-Term Liabilities $1.300M $2.610M $3.070M
Total Liabilities $2.119M $3.030M $3.330M
YoY Change -30.05% -34.13% -10.0%
SHAREHOLDERS EQUITY
Retained Earnings -$153.4M
YoY Change
Common Stock $176.6K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.98M $6.350M $10.02M
YoY Change
Total Liabilities & Shareholders Equity $22.10M $9.370M $13.35M
YoY Change 135.85% -1.06% -7.29%

Cashflow Statement

Concept 2014 Q2 2013 Q2 2011
OPERATING ACTIVITIES
Net Income -$643.0K -$2.378M -$19.43M
YoY Change -72.96% -37.96% 4.76%
Depreciation, Depletion And Amortization $170.0K $170.0K $7.356K
YoY Change 0.0% 0.0% -98.92%
Cash From Operating Activities -$3.420M -$1.970M -$17.20M
YoY Change 73.6% -32.3% 25.28%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $6.147K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$6.147K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.900M 2.290M 16.83M
YoY Change 113.97% 10.1% -9.44%
NET CHANGE
Cash From Operating Activities -3.420M -1.970M -17.20M
Cash From Investing Activities 0.000 0.000 -6.147K
Cash From Financing Activities 4.900M 2.290M 16.83M
Net Change In Cash 1.480M 320.0K -380.4K
YoY Change 362.5% -138.55% -107.84%
FREE CASH FLOW
Cash From Operating Activities -$3.420M -$1.970M -$17.20M
Capital Expenditures $0.00 $0.00 $6.147K
Free Cash Flow -$3.420M -$1.970M -$17.21M
YoY Change 73.6% -32.3% 25.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2002Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2014Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
33334 shares
CY2002Q2 us-gaap Stockholders Equity
StockholdersEquity
802
CY2013Q2 us-gaap Litigation Reserve
LitigationReserve
100000
CY2014Q2 us-gaap Loss Contingency Receivable
LossContingencyReceivable
2240000
CY2014Q2 pvct Reimbursement Receivable Percentage
ReimbursementReceivablePercentage
0.25 pure
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4636020
CY2013Q2 pvct Common Stock Unit Beneficial Conversion Amount
CommonStockUnitBeneficialConversionAmount
1025950
CY2013Q2 pvct Common Stock Unit Fair Value Of Warrants Recorded On Issuance
CommonStockUnitFairValueOfWarrantsRecordedOnIssuance
1297950
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3036218 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176638439 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176638439 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.00
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
176638439 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
372000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
432763
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
816467
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
176638
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153361503
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
19979557
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
232568
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22098985
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7796177
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
173164422
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
104042
CY2014Q2 us-gaap Liabilities
Liabilities
2119428
CY2014Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
479857
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18126036
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26681
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3919268
CY2014Q2 us-gaap Assets
Assets
22098985
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
18126036
CY2014Q2 pvct Number Of Non Employee To Whom Consulting Services Paid
NumberOfNonEmployeeToWhomConsultingServicesPaid
1 Directors
CY2014Q2 pvct Warrant Liability
WarrantLiability
1302961
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
11723580
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
10251052
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
9161701
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
14387141
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
15522400
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
14831510
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
10055536
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
9406510
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
10699573
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
10019740
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4393484
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1221701
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159751724 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159751724 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
429331
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
33
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
512946
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
159752
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146050820
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6628666
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
102795
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20008184
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7460617
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152519701
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
61282
CY2013Q4 us-gaap Liabilities
Liabilities
13379518
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
348869
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15696243
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30113
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4254828
CY2013Q4 us-gaap Assets
Assets
20008184
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
15696243
CY2013Q4 pvct Warrant Liability
WarrantLiability
12866572
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4945316
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
123926235 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Operating Income Loss
OperatingIncomeLoss
-6533534
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7697513
us-gaap Net Income Loss
NetIncomeLoss
-6547555
us-gaap Investment Income Interest
InvestmentIncomeInterest
283
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
93034
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1518865
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
335560
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3414319
us-gaap Depreciation
Depreciation
3100
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
81437
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8359635
us-gaap Dividends Preferred Stock
DividendsPreferredStock
1149958
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4679109
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-178673
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
1341295
pvct Net Proceeds From Sales Of Preferred Stock And Warrants
NetProceedsFromSalesOfPreferredStockAndWarrants
2550000
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
-14304
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-14304
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
5817698
pvct Cash Paid For Preferred Dividend
CashPaidForPreferredDividend
29063
pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
21000
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
98250
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
PROVECTUS BIOPHARMACEUTICALS, INC.
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6268093
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
172225322 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Entity Central Index Key
EntityCentralIndexKey
0000315545
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Operating Income Loss
OperatingIncomeLoss
-8541491
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7310683
us-gaap Net Income Loss
NetIncomeLoss
-7310683
us-gaap Investment Income Interest
InvestmentIncomeInterest
2816
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
85000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2183418
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
335560
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2429793
us-gaap Depreciation
Depreciation
3432
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
172533
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8697886
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6022513
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
130988
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
1350319
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
1227992
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
1227992
pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
4327886
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
4350000
pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
4347886
pvct Amount Reclassified From Warrant Liability To Equity
AmountReclassifiedFromWarrantLiabilityToEquity
10355619
pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1350319
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
277750
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
277750
pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
4350000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
300000 shares
CY2002Q2 pvct Common Stock Issued Under Recapitalization Transactions
CommonStockIssuedUnderRecapitalizationTransactions
6680000 shares
CY2014Q2 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
1120000
CY2014Q2 pvct Future Payments Ratio Of Contingent Consideration
FuturePaymentsRatioOfContingentConsideration
2 pure
CY2014Q2 pvct Annual Cash Bonus Percentage
AnnualCashBonusPercentage
0.70 pure
CY2014Q1 pvct Convertible Preferred Stock Shares To Be Converted To Common Stock Shares
ConvertiblePreferredStockSharesToBeConvertedToCommonStockShares
0 shares
us-gaap Net Income Loss
NetIncomeLoss
-5749937
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
126587
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
48000
pvct Stock Issued For Acquisition
StockIssuedForAcquisition
12226320
pvct Stock And Warrant Issued During Period Value
StockAndWarrantIssuedDuringPeriodValue
27000
pvct Warrant Exercised During Period Value
WarrantExercisedDuringPeriodValue
453
pvct Stock Issued During Period In Reverse Merger Value
StockIssuedDuringPeriodInReverseMergerValue
-3645
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
5144000
CY2014Q1 pvct Convertible Preferred Stock Shares To Be Converted To Common Stock Shares
ConvertiblePreferredStockSharesToBeConvertedToCommonStockShares
33334 shares
CY2014Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-3155313
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
601000
CY2003 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
34659
CY2003 pvct Adjustments To Additional Paid In Capital Stock To Be Issued For Services Value
AdjustmentsToAdditionalPaidInCapitalStockToBeIssuedForServicesValue
281500
CY2003 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
145479
CY2003 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
380347
CY2003 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
239800
CY2005 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3049362
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-11763853
CY2005 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1633176
CY2005 pvct Adjustments To Additional Paid In Capital Beneficial Conversion Related To Interest Expense Value
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionRelatedToInterestExpenseValue
39529
CY2005 pvct Adjustments To Additional Paid In Capital Issuance Of Warrants For Contractual Obligations Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsForContractualObligationsValue
985010
CY2005 pvct Adjustments To Additional Paid In Capital Repurchase Of Beneficial Conversion Feature Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfBeneficialConversionFeatureValue
144128
CY2005 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
15752
CY2005 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
1439795
CY2005 pvct Adjustments To Additional Paid In Capital Issuance Of Convertible Debt With Warrants Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfConvertibleDebtWithWarrantsValue
1574900
CY2005 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
196031
CY2005 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
6513176
CY2005 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1534405
CY2005 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
152285
CY2006 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1576336
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-8870579
CY2006 pvct Adjustments To Additional Paid In Capital Beneficial Conversion Related To Interest Expense Value
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionRelatedToInterestExpenseValue
16447
CY2006 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
1862456
CY2006 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
1189816
CY2006 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
183596
CY2006 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
4130421
CY2006 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
370023
CY2006 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
676743
CY2007 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
367500
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-10005631
CY2007 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
2340619
CY2007 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
3985641
CY2007 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
1258
CY2007 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
1848138
CY2007 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
472635
CY2007 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
298950
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-12322314
CY2009 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
870937
CY2009 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
2524453
CY2009 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
6518688
CY2009 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1064210
CY2009 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
695000
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-18552102
CY2010 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
3759650
CY2010 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
3103680
CY2010 pvct Preferred Stock Issued During Period Pursuant To Regulation Of Value
PreferredStockIssuedDuringPeriodPursuantToRegulationOfValue
4217390
CY2010 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1141593
CY2010 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
419250
CY2010 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
856613
CY2010 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
6346989
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-19434699
CY2011 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
3368950
CY2011 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
6623311
CY2011 pvct Adjustment To Additional Paid In Capital Sale Of Non Controlling Interest And Warrants
AdjustmentToAdditionalPaidInCapitalSaleOfNonControllingInterestAndWarrants
443500
CY2011 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
945116
CY2004 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
495480
CY2011 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
332750
CY2011 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
7041239
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-27697744
CY2013 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
29063
CY2013 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
142310
CY2013 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
7835470
CY2013 pvct Preferred Stock Issued During Period Pursuant To Regulation Of Value
PreferredStockIssuedDuringPeriodPursuantToRegulationOfValue
1252050
CY2013 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1786824
CY2013 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
526000
CY2013 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
18419335
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-4344525
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
360256
CY2004 pvct Adjustments To Additional Paid In Capital Repurchase Of Beneficial Conversion Feature Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfBeneficialConversionFeatureValue
258345
CY2004 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
15612
CY2004 pvct Adjustments To Additional Paid In Capital Issuance Of Convertible Debt With Warrants Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfConvertibleDebtWithWarrantsValue
105250
CY2004 pvct Warrant Exercised During Period Value
WarrantExercisedDuringPeriodValue
5000
CY2004 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
1288861
CY2004 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
793137
CY2004 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
449923
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-10269571
CY2008 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
1946066
CY2008 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
2639711
CY2008 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
517820
CY2008 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
390000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-12568354
CY2012 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
183028
CY2012 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1512026
CY2012 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
456500
CY2012 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
4790544
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92175185
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2385959
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
36637186
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55075
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96570
us-gaap Net Income Loss
NetIncomeLoss
-153361503
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-825867
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2261584
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7796177
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18126036
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
456800
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
443500
us-gaap Depreciation
Depreciation
455764
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
180075
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14540039
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3845721
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
486240
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
109844421
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6706795
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
37010481
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
476212
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
9333712
pvct Net Proceeds From Sales Of Preferred Stock And Warrants
NetProceedsFromSalesOfPreferredStockAndWarrants
11458131
pvct Amortization Of Commitment Fee
AmortizationOfCommitmentFee
310866
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
-7530937
pvct Net Proceeds From Loans From Stockholder
NetProceedsFromLoansFromStockholder
174000
pvct Amortization Of Prepaid Consultant Expense
AmortizationOfPrepaidConsultantExpense
1295226
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
65583856
pvct Cash Paid For Preferred Dividend
CashPaidForPreferredDividend
29063
pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
28859292
pvct Premium Paid On Extinguishments Of Debt
PremiumPaidOnExtinguishmentsOfDebt
170519
pvct Convertible Interest
ConvertibleInterest
389950
pvct Accretion Of United States Treasury Bills
AccretionOfUnitedStatesTreasuryBills
373295
pvct Loss On Exercise Of Warrants
LossOnExerciseOfWarrants
236146
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
9857261
pvct Beneficial Conversion Of Convertible Interest
BeneficialConversionOfConvertibleInterest
55976
pvct Compensation Through Issuance Of Stock
CompensationThroughIssuanceOfStock
932000
pvct Issuance Of Warrants For Contractual Obligations
IssuanceOfWarrantsForContractualObligations
985010
pvct Cash Paid For Deferred Loan Costs
CashPaidForDeferredLoanCosts
747612
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8098004
us-gaap Gross Profit
GrossProfit
24541
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
25648
us-gaap Sales Revenue Net
SalesRevenueNet
39757
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55075
us-gaap Operating Income Loss
OperatingIncomeLoss
-137619128
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-165388213
us-gaap Net Income Loss
NetIncomeLoss
-153361503
us-gaap Investment Income Interest
InvestmentIncomeInterest
657358
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-825867
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48877826
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15216
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7796177
us-gaap Dividends Preferred Stock
DividendsPreferredStock
12026710
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80969666
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-7530937
pvct Medical Device Revenue
MedicalDeviceRevenue
14109
CY2013Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
859833 shares
CY2013Q1 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
-311062
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1924973 shares
CY2013Q1 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
409640
CY2014Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08 pure
CY2014Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
121500 shares
CY2014Q1 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
-1153835
CY2014Q1 pvct Warrants Exercised On Cashless Basis
WarrantsExercisedOnCashlessBasis
12522198 shares
CY2014Q1 pvct Aggregate Exercise Price Of Warrants Exercised
AggregateExercisePriceOfWarrantsExercised
2672364
CY2014Q1 pvct Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
3036218 shares
CY2014Q1 pvct Stock Issued During Period Shares Warrants Exercised On Cashless Basis
StockIssuedDuringPeriodSharesWarrantsExercisedOnCashlessBasis
9100824 shares
CY2014Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
733000 shares
CY2014Q1 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
900317
CY2013Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
127114868 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3286835
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2450397
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2377373
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
256
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
778349
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167780
CY2013Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
73024
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2340706
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1051500 shares
CY2013Q2 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
909206
CY2013Q2 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
221149
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
2605000 shares
CY2013Q2 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
931655
CY2014Q2 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
2000000 shares
CY2014Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
175554000 shares
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4159884
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-643416
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-643416
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1443
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1025535
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167780
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2966569
CY2014Q2 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
5000000
CY2014Q2 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
2.50
CY2014Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
315000 shares
CY2014Q2 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
3515025
CY2014Q2 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
186262
CY2014Q2 pvct Warrants Exercised On Cashless Basis
WarrantsExercisedOnCashlessBasis
1594082 shares
CY2014Q2 pvct Aggregate Exercise Price Of Warrants Exercised
AggregateExercisePriceOfWarrantsExercised
372000
CY2014Q2 pvct Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
372000 shares
CY2014Q2 pvct Stock Issued During Period Shares Warrants Exercised On Cashless Basis
StockIssuedDuringPeriodSharesWarrantsExercisedOnCashlessBasis
915467 shares
CY2014Q2 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
1.00 pure
CY2014Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
202000 shares
CY2014Q2 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
450002
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Net Income Loss
NetIncomeLoss
-1316198
pvct Stock Issued During Period To Employees Value
StockIssuedDuringPeriodToEmployeesValue
932000
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
360000

Files In Submission

Name View Source Status
0001193125-14-299064-index-headers.html Edgar Link pending
0001193125-14-299064-index.html Edgar Link pending
0001193125-14-299064.txt Edgar Link pending
0001193125-14-299064-xbrl.zip Edgar Link pending
d754969d10q.htm Edgar Link pending
d754969dex106.htm Edgar Link pending
d754969dex311.htm Edgar Link pending
d754969dex312.htm Edgar Link pending
d754969dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pvct-20140630.xml Edgar Link completed
pvct-20140630.xsd Edgar Link pending
pvct-20140630_cal.xml Edgar Link unprocessable
pvct-20140630_def.xml Edgar Link unprocessable
pvct-20140630_lab.xml Edgar Link unprocessable
pvct-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending